Rubius Snags $25M to Engineer Red Blood Cells Into Drugs

December 10, 2015 | Flagship Ventures-funded Rubius Therapeutics wants to insert genes for therapeutic enzymes into blood-forming stem cells, then infuse the nucleus-free mature cells into patients to fight disease. Forbes